Common Stock SEC Reporting - Current
Verified Company Profile 8/16/2016
Contact Info
  • 4721 Ironton Street
  • Building A
  • Denver, CO 80239

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001415684
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2006
Employees 85 a/o Jan 27, 2011
Company Officers/Contacts
Ryan Drexler Interim CEO
Peter Lynch CFO
John Price Secretary
Jena Sellers Director, Financial Reporting
Douglas West Controller
Company Directors
Ryan Drexler Chairman
Michael Doron
Stacey Jenkins
Company Notes
  • Formerly=Tone in Twenty until 3-2010
Service Providers
Accounting/Auditing Firm
Ehrhardt Keefe Steiner & Hottman PC
7979 E. Tufts Ave
Suite 400
Denver, CO, 80237
United States

Legal Counsel
61 Broadway
New York, NY, 10006
United States

Investor Relations Firm
Not Available
MSLP Security Details
Share Structure
Market Value1 $29,882,909 a/o Dec 09, 2016
Authorized Shares 100,000,000 a/o Mar 31, 2016
Outstanding Shares 13,834,680 a/o Nov 01, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 9,926,661 a/o Mar 31, 2016
Par Value 0.001
Transfer Agent(s)
Corporate Stock Transfer, Inc.
Shareholders of Record 341 a/o Mar 17, 2016
Short Selling Data
Short Interest 233,805 (-0.74%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security